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Abstract 
 
Neurodegenerative disorders are a diverse group of disorders that affect specific subsets 
of neurons. Motor neuron diseases, neurodegenerative disorders of motor neurons, are 
seen commonly as sporadic cases and less frequently as familial disease forms. The 
familial forms show genetic and phenotypic heterogeneity. Clinically motor neuron 
diseases may be seen as rapidly progressive disorders like amyotrophic lateral sclerosis, 
ALS or slowly progressive disorders like hereditary motor neuropathies, HMN.  
The only proven causes for motor neuron diseases are gene mutations that lead to motor 
neuron degeneration in familial disease forms. Only some of these genes have been 
identified and have contributed greatly to our understanding of the neurobiology of 
familial and sporadic disease forms. Identification of additional disease causing genes 
would help enhance our knowledge of the pathophysiological mechanisms underlying 
all forms of motor neuron disorders, which would lead to early diagnoses, effective 
prophylaxis and efficient therapies for these disorders. 
This study aimed to find gene mutations that cause rapid and slowly progressive familial 
motor neuron disorders in Australian families and to determine their relevance to 
sporadic forms of motor neuron disease. 
The familial forms of ALS show reduced disease penetrance, that is, not all gene 
mutation carriers manifest the disease. This study examines ALS penetrance in a group 
of Australian families. The most frequently observed mutations in ALS families are 
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cytosolic superoxide dismutase/SOD1 gene mutations. In a collection of ALS families in 
our centre, families without the common SOD1 gene mutations were genotyped for 
other ALS genes and loci and studied using genetic linkage and haplotype analyses. 
Studies in a large Australian ALS family further confirmed genetic heterogeneity in non-
SOD familial ALS, all known autosomal dominant ALS genes and chromosomal loci 
were excluded as cause of disease in this family. Such families can be studied further to 
identify additional disease genes and loci mapped in other ALS families. These families 
represent powerful resources for identification of additional ALS genes. Identifying the 
pathogenic genes in families with reduced disease penetrance may be more relevant to 
sporadic forms of disease. 
dHMN is a chronic neurodegenerative disorder predominantly affecting motor neurons. 
In a large Australian dHMN family, all the known dHMN genes and chromosomal loci 
were excluded as cause of disease. A genome wide microsatellite screen was performed 
in this family and genetic linkage was established to a novel 12.98 Mb locus on 
chromosome 7q34.2-q36. Candidate genes in this large interval will be screened based 
on their function and expression profile. Identification of a new dHMN locus provides 
the basis for future identification of a novel gene involved in motor neuron degeneration. 
Genes in dHMN have been shown to be pathogenic in ALS and Charcot Marie Tooth 
syndromes. The new locus for dHMN mapped in this project would lead to identification 
of a novel dHMN gene, which may elucidate the pathogenesis underlying a wide range 
of neurodegenerative disorders. 
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